RNA Splicing: The Process, Mechanism, and Types Explained

RNA Splicing Explained: Process, Mechanism & Types

RNA Splicing: The Process, Mechanism, and Types Explained

Genetic information doesn’t leave the nucleus exactly as it was transcribed. Before a eukaryotic messenger RNA is ready to direct protein synthesis, large internal chunks of the transcript are cut out, and the remaining pieces are stitched back together. This editing step — RNA splicing — is one of the most important, and historically one of the most surprising, discoveries in molecular biology: it revealed that RNA itself can act as an enzyme, reshaping how scientists think about the origin of life.

What Is RNA Splicing?

When a gene is transcribed, the result is a primary transcript — called pre-mRNA in eukaryotes — a raw copy of the gene that still contains non-coding stretches interrupting the coding sequence. These interrupting, non-coding segments are called introns; the segments that remain in the mature RNA are called exons. RNA splicing is the process that removes the introns and joins the exons into one continuous, functional sequence.

How RNA splicing converts pre-mRNA into mature mRNA A pre-mRNA strand made of Exon 1, an Intron, and Exon 2 is spliced so that the intron is removed and Exon 1 joins directly to Exon 2 in the mature mRNA.Pre-mRNA (primary transcript) 5′ Exon 1 Intron Exon 2 3′ RNA SPLICINGMature mRNA 5′ Exon 1 Exon 2 3′
The intron is excised and degraded; only the joined exons remain in the mature mRNA.

Splicing isn’t the only thing that happens to a eukaryotic pre-mRNA before it’s ready for translation. The 5′ end typically receives a modified nucleotide called a cap, and the 3′ end is cleaved and extended with a long stretch of adenine nucleotides — the poly(A) tail. These three processing events — capping, splicing, and polyadenylation — don’t happen independently. They’re carried out by protein complexes that physically associate with one another and with RNA polymerase II as it transcribes, and the same machinery hands the finished mRNA off for export to the cytoplasm. In practice, a newly made mRNA is never “naked” — it’s wrapped in a shifting cast of dozens of proteins from the moment it’s transcribed until it reaches a ribosome.

Splitting genes into exons and introns turns out to be central to how eukaryotic cells generate protein diversity (more on that below), and the machinery that carries out splicing turns out to be one of the most unusual — and RNA-based — systems in the cell.

Types of Introns and How They’re Spliced

Not all introns are removed the same way. Molecular biologists group introns into four classes, based on the splicing chemistry involved and the machinery required.

Group I Introns

Group I introns turn up in a scattered set of nuclear, mitochondrial, and chloroplast genes that encode rRNAs, mRNAs, and tRNAs, as well as in the rare introns found in bacteria. Remarkably, they are self-splicing — the intron itself catalyzes its own removal, with no protein enzyme required.

The reaction needs a free guanosine (or a related guanine nucleotide) as a cofactor, but not as an energy source. Instead, the 3′-hydroxyl group of that guanosine acts as a nucleophile, attacking the phosphate at the 5′ splice site. This is the first of two transesterification reactions: one phosphate bond is broken as a new one forms in its place, so no external energy input such as ATP is needed. The 3′-OH freed at the end of the upstream exon then attacks the 3′ splice site in the second step, releasing the intron and ligating the exons together with chemical precision.

Group II Introns

Group II introns are found mainly in the mitochondrial and chloroplast transcripts of fungi, algae, and plants, and occasionally in bacteria. Like group I introns, they’re self-splicing and need no protein enzyme and no ATP. The chemistry is nearly identical — two sequential transesterification reactions — but the nucleophile in the first step is different: instead of an external guanosine, it’s the 2′-hydroxyl group of a specific adenosine sitting within the intron itself. That internal attack loops the intron back on itself, producing a distinctive branched lariat structure as a splicing intermediate.

Spliceosomal Introns

The great majority of introns in eukaryotic nuclear pre-mRNA fall into a third category. They use essentially the same lariat-forming, two-step transesterification chemistry as group II introns, but they can’t splice themselves — the reaction takes place inside a massive, dynamic protein-RNA machine called the spliceosome (more on this below). Because their removal depends on this dedicated machinery rather than the intron’s own catalytic ability, they’re simply called spliceosomal introns rather than being assigned a group number.

A Fourth Class: tRNA Introns

A small, distinct set of introns found in some transfer RNAs is spliced by an entirely different route: dedicated protein enzymes, rather than RNA catalysis, cut and rejoin the tRNA. These are the only known introns whose removal doesn’t rely on RNA-based chemistry at some stage.

The Discovery That Changed How We Think About RNA

Self-splicing introns weren’t just a biochemical curiosity — their discovery reshaped a core assumption of biology. Until the early 1980s, virtually every known biological catalyst was a protein. That changed in 1982, when Thomas Cech and his research group, studying the group I intron in the ribosomal RNA of the ciliated protozoan Tetrahymena thermophila, showed that the intron could excise itself from an RNA transcript with no protein enzyme present at all.

The finding meant that RNA — long viewed purely as a passive carrier of genetic information — could also act as a catalyst. These catalytic RNAs became known as ribozymes, and the discovery fed directly into the “RNA world” hypothesis: the idea that early life may have relied on RNA molecules to both store genetic information and catalyze the reactions needed to sustain themselves, before protein enzymes and DNA took over those roles. Cech shared the 1989 Nobel Prize in Chemistry with Sidney Altman, who had independently discovered a different catalytic RNA, the ribonucleoprotein enzyme ribonuclease P.

The Spliceosome: A Machine Built From RNA and Protein

Spliceosomal introns — the majority of introns in a typical eukaryotic gene — are removed by the spliceosome, a large complex assembled from five small nuclear ribonucleoproteins, abbreviated snRNPs (commonly pronounced “snurps”). Each snRNP pairs one small nuclear RNA (snRNA), typically 100 to 200 nucleotides long, with a set of associated proteins. Five of these snRNAs — named U1, U2, U4, U5, and U6 — make up the core of the splicing machinery in eukaryotic nuclei.

The spliceosome is not a small assembly. In yeast, roughly 100 different proteins take part, most with clear counterparts across other eukaryotes; in humans, more than 200 additional proteins are layered on top of that conserved core, making the spliceosome one of the largest and most intricate molecular machines found in any cell. What’s striking is that the RNA components, not the proteins, carry out the catalytic chemistry — the protein-rich complex functions more like an adaptable chaperone, positioning and repositioning the catalytic RNA correctly for pre-mRNAs of very different lengths and sequences.

Step by Step: How the Spliceosome Removes an Intron

Spliceosome assembly and catalysis proceed through a defined, ordered sequence of RNA–RNA and RNA–protein interactions:

  1. Splice sites are marked. Spliceosomal introns almost always begin with the two bases GU and end with AG — these short, highly conserved sequences flag the 5′ and 3′ splice sites to the splicing machinery.
  2. U1 binds the 5′ splice site. The U1 snRNA carries a sequence complementary to the region around the 5′ splice site, and the U1 snRNP base-pairs directly with it.
  3. U2 binds the branch site. With help from the protein factor U2AF (and displacing another factor, BBP/SF1, in the process), U2 snRNP binds the branch-point sequence, forming what’s known as the A complex. The base pairing here pushes the branch-point adenosine out of the RNA helix as a single unpaired bulge, precisely positioning the nucleotide that will later act as the nucleophile.
  4. The tri-snRNP arrives. U4, U5, and U6 join together as a single tri-snRNP particle — U4 and U6 held together by base pairing between their RNAs, U5 attached more loosely through protein contacts — and join the complex, converting it into the B complex.
  5. U1 is swapped for U6. U1 releases from the 5′ splice site and U6 takes its place, which requires breaking the original U1–pre-mRNA pairing and forming a new U6–pre-mRNA pairing.
  6. U4 departs, activating the core. Releasing U4 frees U6 to pair with U2 instead, assembling the catalytic center that carries out the two transesterification reactions and excises the intron as a lariat.

Assembling all of this machinery correctly takes energy — ATP powers the various rearrangements — but, just as with the self-splicing group I and group II introns, the actual bond-breaking and bond-forming chemistry of splicing needs no ATP at all. The catalytic work is done entirely by RNA.

Why RNA Splicing Matters

Because of splicing, a typical eukaryotic gene is a mosaic: blocks of protein-coding sequence interrupted by non-coding stretches that must be precisely stitched out before translation. That precision isn’t optional — the triplet codons of an mRNA are read in a fixed frame set by the first codon of the coding sequence, so losing or adding even a single nucleotide at a splice junction would throw every codon downstream out of register and typically wreck the resulting protein.

This “cut-and-paste” arrangement also turns out to be a major source of biological flexibility. Because a single primary transcript can, in principle, be spliced in more than one way, a single gene can give rise to multiple distinct mRNAs — and therefore multiple protein variants — depending on which exons are included in the final message. This alternative splicing is one of the main reasons the human proteome is so much larger and more varied than the roughly 20,000 protein-coding genes in the genome would otherwise suggest.

The flip side is that splicing errors carry real consequences. Mutations that disrupt a splice site, or disrupt the machinery that recognizes it, are an important and often underappreciated cause of human genetic disease, and correcting faulty splicing is now an active area of therapeutic research.

Key Takeaways

  • Introns are the non-coding sequences removed from a primary transcript; exons are the coding sequences joined together to form the mature RNA.
  • Group I and group II introns are self-splicing ribozymes — no protein enzyme is required, though group I splicing needs a free guanosine cofactor.
  • Most nuclear pre-mRNA introns are spliceosomal introns, removed by the spliceosome — a large, dynamic complex of five snRNPs (U1, U2, U4, U5, U6) plus hundreds of associated proteins.
  • Splicing chemistry — in self-splicing introns and in the spliceosome alike — is carried out by RNA, not protein, and needs no ATP; ATP is used only to assemble and rearrange the spliceosome itself.
  • A small class of tRNA introns is the exception: these are spliced by protein enzymes rather than RNA catalysis.
  • Precise splicing preserves the mRNA reading frame, and alternative splicing lets a single gene encode multiple protein products — central to both gene expression accuracy and protein diversity.

Frequently Asked Questions

What is the difference between an intron and an exon?

An exon is a segment of a gene’s transcript that’s retained in the mature RNA and, for protein-coding genes, helps encode the final protein. An intron is a non-coding segment that lies between exons and is cut out during splicing.

What is a spliceosome made of?

The spliceosome is built from five small nuclear ribonucleoproteins (snRNPs) — U1, U2, U4, U5, and U6 — each combining a small nuclear RNA with a set of proteins, plus well over a hundred additional associated proteins.

Do bacteria splice RNA?

Splicing is mainly a eukaryotic phenomenon, but self-splicing group I and group II introns do occur, rarely, in some bacterial genes. Bacteria lack spliceosomes entirely.

Is ATP needed for RNA splicing?

Not for the splicing chemistry itself — the transesterification reactions that cut and rejoin RNA don’t require ATP. ATP is needed to assemble and remodel the spliceosome as it forms around a spliceosomal intron.

Who discovered that RNA could splice itself?

Thomas Cech and colleagues demonstrated self-splicing in a group I intron from Tetrahymena thermophila in 1982, work that contributed to his sharing the 1989 Nobel Prize in Chemistry with Sidney Altman.

What happens if RNA splicing goes wrong?

Errors at splice sites can shift the reading frame, introduce premature stop codons, or produce a faulty protein, and are a well-documented cause of human genetic disease.

References and Further Reading

  1. NCBI Bookshelf – “From DNA to RNA” (Molecular Biology of the Cell)
    Free, in-depth overview of transcription and RNA processing, including splicing.
  2. Annual Review of Biochemistry (2024) – “RNA Splicing by the Spliceosome”
    A detailed, current review of spliceosome mechanism, with illustrative video walkthroughs.
  3. Nature Reviews Molecular Cell Biology (2017) – “Mechanistic insights into precursor messenger RNA splicing by the spliceosome”
    Peer-reviewed review of splicing mechanism and structural biology.
  4. Annual Review of Biophysics (2016) – “Group II Intron Self-Splicing”
    Focused review on group II intron structure and catalytic mechanism.
  5. Wikipedia – “Thomas Cech”
    Background on the 1982 discovery of self-splicing RNA and the 1989 Nobel Prize in Chemistry.

Discover more from Zoologyverse

Subscribe to get the latest posts sent to your email.

Leave a Reply

Discover more from Zoologyverse

Subscribe now to keep reading and get access to the full archive.

Continue reading